title: Influence of topical erythromycin preparations for acne vulgaris on skin surface pH.
abstract: Topical erythromycin is a standard regimen for inflammatory acne vulgaris because of its action against Propionibacterium acnes. Changes in P. acnes colonization are inducible by long-lasting changes of skin surface pH. Therefore, the influence of six erythromycin preparations with approximative pH values of 7.5 (preparation A) to 10.2 (C) on the skin surface pH was evaluated in healthy volunteers using a cross-over design. Following a 14-day run-in period, a constant skin surface pH (5.0) was found. Ten subjects received single doses 2-3 days apart; 20 volunteers applied preparations A and C for 28 days. Single doses of preparations A and E (pH 8.0) increased skin pH to 6.99 and 8.61, respectively, at 15 min; it then gradually declined. The other preparations induced only a minor rise of short duration. At the end of the long-term application, the skin surface pH amounted to 5.73 (A) and 5.39 (C). There was no correlation between the effect on skin surface pH and the approximative pH of the preparations. A close relation of single-dose and long term-effects was observed, however. The skin surface pH during the application of preparation A is high enough to increase P. acnes growth about fourfold as compared with normal skin and thus may counteract the antibacterial effect. Clinical relevance should be evaluated in a controlled clinical trial comparing the efficacy of preparation A with that of preparation C.
authors.affiliation: Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.
authors.forename: H C
authors.initials: HC
authors.lastname: Korting
authors.forename: M
authors.initials: M
authors.lastname: Kerscher
authors.forename: M
authors.initials: M
authors.lastname: Schäfer-Korting
authors.forename: U
authors.initials: U
authors.lastname: Berchtenbreiter
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000279:Administration, Cutaneous; D000328:Adult; D004334:Drug Administration Schedule; D004917:Erythromycin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D012016:Reference Values; D012867:Skin / Q000187:drug effects*
chemical_list: D004917:Erythromycin